Zealthy Review

Zealthy — Provider Profile

Overview

Zealthy is a physician-supervised telehealth platform with a specific focus on insurance navigation for branded GLP-1 medications. Most telehealth GLP-1 providers operate as cash-pay-first platforms — they price compounded options competitively because insurance coverage for brand-name GLP-1s is difficult to obtain. Zealthy inverts that approach. Its clinical strength is helping insured patients get branded medications (Wegovy, Zepbound) covered, with prior authorization support built into the program.

For patients with employer or commercial insurance that covers GLP-1s for weight loss — and many now do — the prior authorization process is the primary barrier. Zealthy's physicians handle that process as part of the service. For insured patients who have been denied coverage or haven't tried the insurance route, Zealthy is worth a direct comparison against cash-pay compounded options.

For patients without insurance coverage, Zealthy does offer compounded GLP-1 options as an alternative pathway. However, Zealthy's pricing on the cash-pay side is less transparent than providers built around that model, and the platform's differentiation comes primarily from its insurance navigation capability.

April 2026 context: Where Zealthy prescribes compounded GLP-1s, the standard regulatory context applies: compounded medications are not FDA-approved, and the sector is under active FDA enforcement pressure. Brand-name prescriptions are FDA-approved and not affected by compounding regulations.

Pricing and protocol data sourced from this provider's public website, verified April 2026. Patient experience data from verified patient reports. We have no commercial relationship with this provider.

Medications Offered

• Brand-name semaglutide (Wegovy) — FDA-approved; primary focus for insured patients
• Brand-name tirzepatide (Zepbound) — FDA-approved; available through insurance pathway
• Compounded GLP-1 options — Not FDA-approved; available for patients without insurance coverage

Pricing

Pricing last verified April 2026. Confirm current pricing directly with the provider before enrolling.

Cash-pay pricing is not published prominently; insurance-track patients are the primary audience. If you're paying out of pocket, compare Zealthy's cash-pay pricing directly against Belle Health, Eden Health, or Henry Meds before committing.

States Served

Check zealthy.com for current availability. Multi-state physician-supervised platform.

Insurance

• Consultation: Included in program cost
• Medication (insurance pathway): Zealthy's core model. Physicians handle prior authorization for brand-name Wegovy and Zepbound. Patients with qualifying diagnoses (obesity or weight-related comorbidities) and insurance coverage that includes GLP-1 medications can potentially access brand-name drugs at $25/month copay or less.
• Medication (no insurance): Compounded options available as cash-pay alternative.

Consultation Process

Model: Async intake with physician-supervised insurance navigation.

1. Complete an online intake covering medical history, insurance information, weight loss history, and relevant diagnoses
2. A physician reviews your case and determines eligibility for the insurance pathway
3. If you qualify for the insurance track, the Zealthy team initiates prior authorization on your behalf
4. If approved by your insurer, brand-name medication is covered under your plan's terms
5. If insurance is denied or you have no coverage, the team discusses alternative pathways including compounded options
6. Ongoing provider messaging for dose management and appeals if needed

Pros

• Specializes in insurance prior authorization — meaningful help for insured patients who can't navigate the process alone
• Brand-name GLP-1 access at copay rates ($25/mo or less) for qualifying insured patients
• Physician-supervised model throughout
• Compounded option available for patients without insurance

Cons

• Less transparent on cash-pay pricing than providers built around that model
• Insurance pathway only useful if your plan covers GLP-1s for weight loss (many still don't)
• Not the most competitive option for patients without insurance coverage
• Prior authorization outcomes are not guaranteed — insurer decisions are outside Zealthy's control
• Full state availability needs verification

Best For

Patients with employer or commercial insurance that covers brand-name GLP-1s for weight loss (or that might with the right prior authorization), who haven't been able to navigate the approval process on their own. Zealthy's prior authorization infrastructure is a real service for patients who've been denied or haven't tried the insurance route.

Not ideal for: Patients without insurance coverage who are looking for the cheapest compounded option (try Belle Health, Eden Health, or Henry Meds), or patients who have already confirmed their insurance won't cover GLP-1s for weight loss.

Editorial Verdict

Prior authorization for GLP-1s is difficult. Insurers require specific diagnostic codes, documentation of comorbidities, and often a trial of other interventions before approving brand-name coverage. Many patients give up and go cash-pay. Zealthy's physicians handle that process as part of the service.

Insurance coverage for GLP-1s for weight management is still inconsistent — Medicare, most Medicaid plans, and many employer plans don't cover it. Where a plan doesn't cover GLP-1s for weight loss, Zealthy's primary differentiator doesn't apply, and you'd be evaluating it on cash-pay terms against providers built for that model.

Call your insurer before enrolling to confirm whether your plan covers Wegovy or Zepbound for obesity or weight management. Confirmed coverage makes Zealthy's prior authorization support directly useful. Without it, compare cash-pay options on price and pharmacy quality instead.

Bottom line as of April 2026: Zealthy is built for insured patients who haven't been able to get prior authorization approved for branded GLP-1s. That's a real service for patients who qualify. For cash-pay patients, compare pricing carefully against providers built around that model before committing.

Data Sources

Pricing and protocol information sourced from Zealthy's official website (verified April 2026). Consultation process details sourced from provider onboarding flow documentation. Patient experience descriptions sourced from public patient reviews. Telehealth Ally has no affiliate or commercial relationship with this provider.

Related Content

• Best GLP-1 Weight Loss Programs 2026 — All providers ranked
• GLP-1 Cost & Insurance FAQ — What you'll actually pay
• GLP-1 Compounding Pharmacies: What Patients Need to Know — Full regulatory context